• Major first-mover advantage in proprietary web-based e-commerce platform segment
• Penetrating U.S. independent pharmacy market with total purchases of $92 billion per annum
• Adding 100+ pharmacies per month to its online purchasing platform

Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, procurement, and health care platform that offers health care buyers and sellers of pharmaceuticals procurement, currently has more than 11,900 pharmacies as registered users of its proprietary e-commerce platform. Registered users are under no contract of fee obligations when joining the ‘Supplier-to-Pharmacy’ (S2P) trading platform.

With the current number of users already on the network – serving an estimated 12 to 15 million patients indirectly through these member pharmacies , and adding about 100 new pharmacies per month, Trxade’s goal is to reach most, if not all, of the 24,000 independent pharmacies in the U.S., which have a combined annual purchasing power of more than $92 billion.

Leveraging a robust technology with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features, the platform is designed to help independent pharmacies identify the best available supplier prices for prescription drugs nationwide. The platform allows its members to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving them money by taking advantage of best purchase pricing.

This approach is part of Trxade’s efforts to be one of the driving forces behind a nationwide reduction of pharmaceutical and health care costs. To this end, the company is committed to developing its portfolio of products and services to drive value and growth for all members, employees and investors. Trading platform aside, Trxade also owns a mail order pharmacy and warehouse and drug delivery service through our Delivemeds (www.Delivmeds.com) and Bonum Health (www.BonumHealth.com) a Telehealth App.

The company recently launched a one-of-a-kind Telehealth initiative, called the ‘Bonum Health Hub’, together with wholly owned subsidiary Bonum Health, which partnered with Tampa Bay-based independent retail pharmacy chain Benzer Pharmacy. Bonum and Benzer will locate the Health Hubs in urban and rural areas lacking this type of care. The Hubs will provide capacities and technology to offer care to patients who can afford neither primary nor collaborative care.

The U.S. health care market is currently valued around $4 trillion. As the general population ages, further growth is expected, which in turn will have increasing impact on consumers as out-of-pocket expenses rise as well. Drug costs are expected to increase faster than overall health care costs and well above inflation. Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

• Champignon Brands recently started trading on the Canadian Securities Exchange (CSE)
• The company also enters into definitive agreement to acquire Artisan Growers Ltd
• SHRM specializes in medicinal-mushroom, mushroom-infused products

Champignon Brands Inc. (CSE: SHRM), a wellness company specializing in the formulation and distribution of a group of artisanal-mushroom health supplements, recently began trading on the Canadian Securities Exchange (CSE). In February 2020, SHRM successfully completed an initial public offering (IPO) through lead agent PI Financial Corp. Additionally, Champignon Brands will look to secure a listing on the Frankfurt Stock Exchange and a quotation on the OTC Marketplace in the United States as soon as is feasible (http://ibn.fm/SzJuo).

“We’ve been assembling a dedicated roster of mycologists and health and wellness professionals to formulate several distinctive lines of premium fungi extracts,” Champignon CEO Gareth Birdsall stated in a news release. “The overall product portfolio is tailored for conscious consumers looking to support mental health and bolster cognitive performance through medicinal mushroom-based products.”

As Champignon Brands continues to bolster its product portfolio, the company also recently announced that it entered into a definitive agreement to acquire Artisan Growers Ltd., a British-Columbia-based, craft-mushroom cultivator and supplier. Champignon’s plan is to integrate Artisan Growers’ craft-mushroom production capacity into its existing medicinal-mushroom manufacturing, formulation and distribution infrastructure.

Champignon Brands’ focus is to continue to control its supply chain directly to the end user (http://ibn.fm/LLtPq). Artisan Growers operates a craft-mushroom cultivation facility that can produce an array of organic craft mushroom varietals including lion’s mane, chaga, reishi and agaricus blazei.

SHRM’s dedication is to the cultivation, distribution and proliferation of artisanal-medical mushrooms and associated CPGs (Consumer Packaged Goods). The company crafts its increasingly evolving portfolio with the health-conscious consumer in mind, as evidenced by its flagship brand, Vitality Superteas. A vertically integrated producer of medicinal mushrooms and related products, Champignon Brands is based in Vancouver, British Columbia.

With a passion for transforming conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, SHRM and its offerings align with the medical research community’s renewed interest in mushrooms’ health benefits. “Mushrooms contain protein, vitamins, minerals, and antioxidants. These can have various health benefits,” reported a recent Medical News Today article titled ‘What is the Nutritional Value of Mushrooms?’ (http://ibn.fm/Q7xCB). The article also states that “the antioxidant content in mushrooms may help prevent lung, prostate, breast and other types of cancer, according to the National Cancer Institute.” Harnessing the power of the humble mushroom, Champignon Brands is helping to shape the health and wellness product landscape. Champignon Brands has its premium family of organic, sustainable, vegan and non-GMO (genetically modified organisms) mushroom and mushroom-infused formulations. The company’s Vitality Superteas products includes Nourish Force Supertea, a blend of reishi tyobus tea mix; Mighty Recharge Supertea, created with lion’s mane tropical green ginseng tea mix; and Brain Enhance Supertea, a blend of cordycep hibiscus and berries tea mix.

Aside from its impressive product lineup, the company also has its research and development/product formulation partnership. Champignon and Drip Coffee Social Ltd. entered into this partnership to facilitate Drip Coffee Social infusing Champignon’s proprietary, mushroom-extract blend into a suite of cold-brew coffee products and signature in-house formulations (http://ibn.fm/86VgL). Champignon sees considerable potential in the CPG space.

The expectation is that the worldwide, functional-food marketplace that the company is working to enter will reach $34.3 billion by 2024. For 2020, Champignon Brands’ strategy includes the development of cGMP (Current Good Manufacturing Practice) formulations of bioactive compounds extracted from plants and fungi (http://ibn.fm/Z9gd7).

Champignon Brands is aggressively pursuing its mission of researching and distributing premium-medicinal, mushrooms-infused products. Of note to investors is that the company is targeting high-margin markets and optimizing its e-commerce and fulfillment infrastructure. Champignon Brands continues to promote the health and wellness benefits of functional mushrooms while at the same time offering the potential for significant investor return on investment.

For more information, visit the company’s website at www.ChampignonBrands.com

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

• Artificial Intelligence at the forefront of scientific discovery, proving importance in complex diseases
• Predictive Oncology launches new AI platform in fight against new pathogens
• Artificial intelligence likely to help find COVID-19 vaccines and therapeutics

With the global onslaught of COVID-19, scientists are turning to the speed and power of artificial intelligence to find solutions. The complexity of this lethal contagion demands a rapid response, and only advanced computer systems can parse through massive amounts of data swiftly enough to help stem the pandemic. Artificial intelligence can sort and sift data quickly, spot patterns and make predictions – which can then help identify both potential vaccines and therapeutics. Predictive Oncology Inc. (NASDAQ: POAI) just announced it was entering the fight against the latest scourge and is launching a new artificial intelligence platform to aid in vaccine and drug development to battle coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS and SARS) (http://ibn.fm/BhOzX).

Through an interim operating agreement with Soluble Therapeutics, POAI believes the extensive experience utilizing artificial intelligence in its Helomics division to better understand and battle cancer will prove invaluable in the quest for solutions to the current global health crisis. Combining the HSC(TM) Technology with POAI’s predictive modeling platform is expected to create a new rapid AI discovery platform that quickly and cost-effectively identifies potential therapeutic candidates.

“The combination of Soluble Therapeutics’ technology with Predictive Oncology’s AI capability has the potential to rapidly optimize formulations thereby accelerating the early phase of protein therapeutic development,” HSC(TM) co-inventor Dr. Larry DeLucas stated in a news release (http://ibn.fm/xPLzZ). DeLucas, who flew aboard NASA Space Shuttle mission STS-50 as a payload specialist, is now the director of the Center for Structural Biology at University of Alabama School of Medicine.

Global health experts predict an ever-increasing number of viral outbreaks like COVID-19, and POAI intends to be at the forefront of efforts to identify and aid in the development of new vaccines and therapeutics. Predictive Oncology has enjoyed a business relationship with InventaBioTech and through negotiations signed a letter of intent to acquire Soluble Therapeutics, its assets and, most importantly, its HSC(TM) Technology. The technology dovetails POAI’s efforts against cancer as the HSC(TM) machines can be used in the development of new cancer antibodies and vaccines and create new possibilities in the fight against new pathogens. Soluble Therapeutics has previously worked with many of the major pharmaceutical companies searching for a vaccine such as Gilead Sciences (NASDAQ: GILD), GlaxoSmithKline (NYSE: GSK), Pfizer, Bayer and others.

The HSC(TM) Instrument and underlying technology have been validated over the past ten years via industry and academic collaborations. For biopharmaceutical clients this means faster development times and quicker progression of molecules into the clinic. For academic collaborators, this has meant further progression of structural biology studies necessary to advance research in areas of unmet medical need.

The HSC(TM) Technology accelerates the formulation process and is believed to achieve in a month what can take a team of scientists several months to a year to achieve. Able to do more with less, the technology only requires milligrams of material, where a traditional formulation effort can require up to a gram. Two decades in the making, HSC Technology has demonstrated efficacy with both new and existing vaccine and drug programs, ensuring the best delivery mechanisms to address new pathogens, battle cancers, and enhance the drug development process by rapidly optimizing protein solubility and stability. Protein formulation is often a bottleneck in protein-based drug development, and Soluble Therapeutics’ technology directly addresses this obstacle.

Combining the HSC(TM) Technology with POAI’s predictive modeling platform is expected to create a rapid AI discovery platform that quickly and cost-effectively identifies potential vaccines and therapeutic candidates as well as optimizing protein formulations for stability and higher protein concentrations using FDA approved ingredients.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• CIIX concentrating on multi-pronged growth strategy
• The company operates a top financial-information website, developing CBD initiatives
• CIIX offers investors unique, contemporary ROI opportunities

A fintech enterprise, ChineseInvestors.com Inc. (OTCQB: CIIX) is focusing on its original mission of providing financial information and services to the larger Chinese community in the United States and globally. CIIX has become a leading financial-information website (in Chinese language character sets) for Chinese-speaking investors in the United States and China and continues to pursue new areas for growth in other industries as well (http://ibn.fm/TBCJS).

Via its website, www.ChineseInvestors.com, CIIX offers an array of investor-education products and services. Additionally, the company has recognized exceptional opportunities in the global cannabis industry. Established in 1999, ChineseInvestors.com has its corporate headquarters in San Gabriel, California, with offices in Flushing, New York, and Shanghai, China (http://ibn.fm/RzkQ8).

At the heart of CIIX’s financial information and services is its ChineseInvestors Method. This method is an inventive combination of a disciplined investing process, web-based tools, personalized instructions and invaluable support. The company’s investor-education products and services include real-time market commentary and analysis as well as educational-related services. CIIX also offers consultative services to smaller private companies considering becoming a public company and advertising- and public-relations-related support services.

Moreover, CIIX is laying the foundation to leverage the increasing demand for cannabidiol (CBD)-based nutrition and health products through its wholly owned foreign enterprise, CBD Biotech. Part of a burgeoning contemporary trend, the company is working to be a recognized leader in the hemp-based, CBD-oil industry. According to a Jan. 8 Research and Markets article, a minimum of 190 companies in China include industrial cannabis in their business scope (http://ibn.fm/MXfom).

The article also noted that CBD will become the emphasis for the development of the cannabis industry in China in the future. Nonetheless, industrial cannabis is not yet legal for medical applications in China. Consequently, the market is underdeveloped, resulting in low use of industrial cannabis.

The article further explains that as more thorough research is conducted in the field of cannabis, the marketplace for CBD extracts is growing. As that occurs, the application of CBD in food, cosmetics and health products will continue to multiply.

The dynamic CBD industry is a rising market expected to reach $2.1 billion in consumer sales this year. Furthermore, BDS Analytics and Arcview Market Research projects that the collective market for CBD sales in the U.S. will exceed $20 billion by 2024 (http://ibn.fm/p9O4m). BDS Analytics predicts that most CBD product sales will take place in general retail stores instead of cannabis dispensaries.

Astute investors may do well to note how CIIX is well-positioned for growth in this market sector. The company has established a three-year development plan to leverage the merging of CBD and the nutrition with health products market in mainland China. In this marketplace, the benefits of CBD oil have not been broadly recognized.

Based on this wholesale agreement/development plan with a reputable CBD health brand, CIIX initiated the first-ever online, CBD-health products store published in the Chinese language, www.ChineseCBDoil.com. The company sells CBD-infused products both in-store and online. The company’s website caters to an increasing number of Chinese people who are coming to understand the manifold potential health benefits of CBD oil for the treatment of an assortment of conditions, including anxiety, stress, poor sleep, Alzheimer’s disease and other conditions.

ChineseInvestors.com continues to emphasize its two quality revenue channels for sales and profit growth: fintech products and services and CBD programs. Investors may note that in June 2019, the company anticipated the doubling of sales over next 12 months (http://ibn.fm/wyBYE). Also, CIIX is planning an IPO of CBD Biotech early this year. The path ahead looks promising for CIIX along with its visionary management team, customers and investors.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• John Hopkins center for psychedelic research dedicated to discovering potential of mushrooms in support of overall health
• Global functional-food market forecast to reach $34.3 billion by 2024; both reishi, cordyceps consumption expected to be in high demand
• Distribution strategy involves e-commerce, social-media influencer marketing, product formulation and R&D agreement with Drip Coffee Social

Champignon Brands Inc. (CSE: SHRM) is a Canadian-based, research-driven company specializing in the formulation of mushroom-infused CPGs that promote holistic health and wellness. On March 2, 2020, the company saw its first day of trading on the Canadian Securities Exchange (CSE). Committed to sustainability, all SHRM products are organic, non-GMO and vegan certified.

SHRM offers a timely product line. The medical market is becoming more aware of the positive effects of mushrooms for mental health. In 2019, Johns Hopkins launched a center for psychedelic research backed by private funders (http://ibn.fm/mtUhg). At the center, a team of faculty neuroscientists, experimental psychologists, clinicians and postdoctoral scientists is dedicated to discovering the potential of psychedelics as medicine and in the support of overall health.

“The center’s establishment reflects a new era of research in therapeutics and the mind through studying this unique and remarkable class of pharmacological compounds,” said Roland Griffiths, PhD, the center’s director and professor of behavioral biology in the Department of Psychiatry and Behavioral Sciences and the Department of Neuroscience at the Johns Hopkins University School of Medicine. “In addition to studies on new therapeutics, we plan to investigate creativity and well-being in healthy volunteers that we hope will open up new ways to support human thriving.”

Alex Cohen, president of the Steven & Alexandra Cohen Foundation, which is covering the center’s operational expenses for the first five years, explained the foundation’s commitment. “We have to take braver and bolder steps if we want to help those suffering from chronic illness, addiction and mental health challenges,” she said. “By investing in the Johns Hopkins center, we are investing in the hope that researchers will keep proving the benefits of psychedelics – and people will have new ways to heal.”

The focus of John Hopkin’s studies will be on the affect psychedelics have on behavior, brain function, learning and memory, and the brain’s biology and mood. New therapies and the effectiveness of psilocybin are being explored for opioid addiction, Alzheimer’s disease, post-traumatic stress, post-treatment Lyme disease syndrome, anorexia nervosa and alcohol use related to depression.

The use of mushrooms in the health industry is growing in credibility in both scientific and financial sectors, and laws around the use of psilocybin mushrooms and their derivatives are changing. This progress is providing companies such as SHRM the opportunity to support mental health and develop new and improved treatments. The opportunities aren’t only medicinal, so while Champignon is preparing large-scale production for clinical settings, the company is also focused on retail opportunities in the health and wellness market.

The health-conscious consumer is seeking more options – and mushrooms may be the answer. The global functional-food market is forecast to reach $34.3 billion by 2024, and both reishi and cordyceps consumption is expected to experience exponential demand (http://ibn.fm/taxU5). As the ‘shroom boom opens new possibilities in both medicine and functional food, SHRM has plans in place to effectively penetrate the market (http://ibn.fm/AbPn5). The company’s distribution strategy involves e-commerce, social-media influencer marketing, and product formulation and R&D agreement with Drip Coffee Social.

The company’s product formulation and R&D agreement with Drip Coffee Social is designed to develop a ready-to-drink, cold-brew coffee line and hot beverages crafted in-house at Drip Coffee’s flagship location in Nanaimo, British Columbia. This new product line of coffees will be vegan, organic, and fair trade certified (http://ibn.fm/JazXT).

In addition, Champignon’s flagship e-commerce store, VitalitySuperTeas.com, offers various mushroom-infused teas, “tea”-shirts, teacups, teapots and additional accessories. Those who are interested in being social media ambassadors are encouraged to reach out to sales@vitalitysuperteas.com.

For more information, visit the company’s website at www.ChampignonBrands.com

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

• SRAX enters into $5M secured term loan with B. Riley Financial Inc. affiliate
• Company’s BIGtoken platform allows users to own, earn from their data in addition to generating quality data sets that can be sold to marketers
• BIGtoken launches into several international markets including India, Mexico and Europe

SRAX Inc. (NASDAQ: SRAX), a marketing and consumer data management technology company, is positioned to accelerate the growth of its BIGtoken consumer-driven data marketplace after entering into a secured term loan with an affiliate of B. Riley Financial Inc., a diversified financial services company. Details of the transaction can be found in the company’s current report on Form 8-K, filed recently with the SEC (http://ibn.fm/m0ACV).

BIGtoken is a unique offering in the digital marketing space that offers solutions for consumers who are increasingly becoming aware of the value of their data. The platform allows users to own and earn from their data, providing everyone in the ecosystem with choice, clarity and reimbursement, in addition to generating reliable data sets that can be sold to marketers.

“We are excited to partner with B. Riley. The team is experienced and will help us take the next steps in executing our plan,” SRAX founder and CEO Christopher Miglino stated in a news release. “This financing will help fuel growth as both BIGtoken.com and SRAXir.com are gaining traction in their goals to be the leaders in their respective data businesses.”

Increased concerns about data privacy have resulted in millions of users abandoning some of the most popular social media platforms (http://ibn.fm/BCve3). Knowledge among the general public about the value of consumer data is no longer secret as users are becoming increasingly savvy about how tracking mechanisms are being used to record their clicks and track their activities. SRAX aims to leverage this situation by positioning BIGtoken as a solution that bridges the appetites of marketers for high-quality data with the desire of users for fairness and compensation.

“We’re pleased to provide SRAX with the necessary financing to support its growth,” Bryant Riley, Chairman and co-CEO of B. Riley Financial, stated in a news release. “The shifting privacy landscape has required brands and marketers to embrace new technology to reach desired consumer groups, and we believe SRAX is well-positioned to capitalize on this opportunity.”

SRAX’s BIGtoken platform features proprietary technology that allows users to select, approve and monetize their data while simultaneously creating anonymous and reliable data sets that marketers can access for a fee. The available data spans many industry verticals in the automotive, luxury, lifestyle and investor relations spaces, empowering marketers to accurately identify target consumers for brands and companies, giving them a competitive edge with reliable, accurate, user-driven data.

SRAX launched BIGtoken into several international markets by creating local joint ventures such as its recent partnership with the Mumbai-based Yash Birla Group. With diversified interests in both consumer and industrial products, the deal will give the company access to India’s estimated digital population of 627 million – representing one of the largest digital ad markets in the world with an estimated value of $3.6 billion and CAGR of 32%. Further international developments include SRAX Mexico with a team of 90 employees and 70 engineers, in addition to several multilingual offerings of BIGtoken in Europe.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Northwestern University awards SGLB a contract to implement 3D-metal-printing, quality-assurance software on laser melting machine
• Sigma Labs’ unrivaled PrintRite3D software is singular solution for quality assurance roadblocks to 3D-metal-printing industry
• Global 3D-metal-printing market size expected to expand to $3.05 billion by 2025 with a CAGR of 31.8%

Sigma Labs Inc. (NASDAQ: SGLB), the sole provider of in-process quality-assurance software for the commercial 3D metal printing industry, has been awarded a contract by Northwestern University to implement its patented PrintRite3D(R) software. The company’s real-time, melt-pool analytics technology is set to transform the commercial additive-manufacturing space by addressing costly quality control issues – a step required to maximize profits and move forward from the prototype phase to widespread industrialization.

In collaboration with the Northwestern Initiative on Manufacturing Science and Innovation (NIMSI) and the Center for Hierarchical Materials Design (CHiMaD), the PrintRite3D system will be installed on a DMG MORI LASERTEC12 Selective Laser Melting machine. DMG MORI – a global leader in machine tool manufacturing – is expected to capture significant market share of the burgeoning additive manufacturing industry with the LASERTEC12. Sigma Labs will further validate the technological performance and capabilities of PrintRite3D in identifying real-time defect formations during the printing process, in addition to demonstrating its software’s unparalleled capability for third-party, independent, quality-assurance monitoring of metal additive-manufacturing systems.

Following an assessment of the costly quality-control issues impeding the progress of the 3D-metal-printing industry, Sigma Labs realized that the enormous potential of 3D metal printing could only scale up if in-process, quality-assurance tools were developed to observe, manage and control the manufacturing process. With a stated mission of becoming the de facto standard for such monitoring systems, SGLB continues to demonstrate the achievement of these objectives with its patented PrintRite3D software.

“We are honored to have the opportunity to work with Northwestern University,” Sigma Labs Executive Chairman Mark Ruport stated in a news release. “This type of collaboration is critical if additive manufacturing is to realize its potential and reach full industrialization.”

Jian Cao, Cardiss Collins Professor of Mechanical Engineering and NIMSI director, agrees. “Sigma Labs provides us with one critical element in our ICME framework for model validation and for process control,” said Cao. “We look forward to our collaboration [bringing] the science and technology of additive manufacturing to the next level.”

Quality control remains one of the primary impediments to scalability due to the high number of rejected parts found in the post-process stage by costly CAT scans. Sigma Lab’s patented PrintRite3D software addresses this issue during the production phase by monitoring compliance with design and metal quality criteria in real-time to ensure the consistent quality of each part during the manufacturing process, layer by layer. This in-process monitoring and reporting allows operators to stop the production of a defective part and implement solutions during the process – resulting in reduced error rates and higher yields. In addition to being evaluated by tier-1 aerospace and OEM partners worldwide, Sigma Labs has also engaged 19 beta customers across 23 installations.

The global 3D-metal-printing market size is expected to reach $3.05 billion by 2025, progressing at an eye-popping CAGR of 31.8% during the forecast period (http://ibn.fm/eGIUT). As the definitive solution for quality-control issues, PrintRite3D is poised to catalyze this hypergrowth industry, positioning Sigma Labs as a leader in what is often referred to as the next industrial revolution.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• Delivering business solutions designed exclusively for the lucrative cannabis industry
• Expanding portfolio of synergistic portfolio of cannabis service companies
• Creator of Budtender Awards, the first cannabis-related expo and education event on the Las Vegas strip

Round Meadow Holdings Corp. (“RMH”) is a professional organization that represents accountability, delivering business solutions created exclusively for the expanding cannabis industry. A synergistic portfolio of cannabis service companies, RMH is dedicated to supporting the competitive cannabis landscape and its participants as the industry evolves and faces historic growth spurts and challenges.

Historically, when industries such as cannabis experienced growth spurts, many people rushed to find their position within that space. As the competitive landscape increased, so did the velocity of product offerings. For instance, during the Gold Rush of 1849, most successes were found among companies that provided services to the miners rather than with the miners themselves. Levi Strauss and a few well-known hotel chains and banks know all too well the outcome of offering goods and services to an exploding industry.

RMH recognizes numerous opportunities within the current marketplace and has defined its strategy for success in the evolving cannabis industry. At the core of this strategy is a portfolio of synergistic brands, including Canna Paid, Budtender Awards, BudtenderSelect.com, and High Lifestyle. These separate verticals are designed to provide relevant and much-needed services to the cannabis industry. They are interconnected and supportive of each other, strengthening their positions as a whole.

RMH Companies

Canna Paid
Canna Paid is a merchant services platform that utilizes a unique and proprietary compliance technology to provide cannabis merchants a competitive and standard retail banking solution. Canna Paid works with all major credit card brands, and enables users to send and receive electronic payments.

One of the distinct features of the Canna Paid technology, which significantly benefits the user experience, is that it supports and maintains existing consumer behaviors. The process performs in the same manner as a traditional retail credit card transaction, but incorporates tokenization -similar to how Apple Pay works – to secure the transaction at the highest level. This process protects the merchant and cardholder from fraud and unintentional disputes (“chargebacks”). Furthermore, it simply makes it easy for cannabis dispensaries and customers to seamlessly conduct business. As the Canna Paid portfolio continues to expand, so does the brand equity that secures its position as an industry leader.

FAQ: What happens if cannabis becomes legal nationwide, or what if banking becomes more available for cannabis-related businesses? How will this affect Canna Paid?

As an emerging branded technology and industry leader, Canna Paid remains scalable and closely connected to the growth of the industry and the governing regulations.

Further driving Canna Paid’s appeal as the end-to-end solution for a variety of traditional banks and financial institutions is its capability of providing electronic payment solutions that can integrate with POS systems and simultaneously collect transactional data at the point of purchase. If cannabis becomes legal in all 50 U.S. states (de-scheduled), or if traditional banking becomes more available to business owners in this space, the most valuable factor to conventional banking partners will be the contracts and relationships that Canna Paid has secured. The unique advantages that Canna Paid can offer to a traditional banking partner makes it a prime target for a strategic partnership.

Budtender Awards
RMH excited the cannabis community in 2019 with the creation of the “Budtender Awards,” becoming the first-ever cannabis-related expo and education event at an MGM property and the first at any casino on the Las Vegas strip.

The modern-day “Budtender” is an individual who is helping to redefine and elevate what it means to be someone who works in a dispensary or store where medical or recreational cannabis is sold. Increasingly, this subculture is evolving into a group of highly educated professionals who are continually developing their unique blend of style, food, entertainment, music, fashion, and, most importantly, their recommendations to an ever-growing variety of cannabis offerings. They are educators, advisors, sales professionals, occasionally a “therapist,” and often a trusted resource or friend to their customers.

No matter the role, they are the frontline of the cannabis industry who stand between the thousands of emerging brands, and their would-be customers. Amid this developing group are rising stars who are making a significant impact on the cannabis culture itself.

The 2020 Budtender Awards Experience will take place Sept. 17-19 in Las Vegas at Mandalay Bay Resort and Casino with a full slate of brand activations, pop-up giveaways, vendors, product samples, brand certifications, industry speakers, educational panels, and a Budtender Bootcamp. Networking opportunities, along with a poolside concert series and exclusive VIP parties, add to the unique and exciting atmosphere for expo participants.

Clover Leaf University (“CLU”), the first accredited university specializing in phytotechnology to be approved, regulated, and licensed by the Colorado Department of Higher Education’s Private Occupational School Board, will provide Budtender educational opportunities covering a wide range of topics. CLU delivers the highest quality industry training and the most comprehensive curriculum available today.

Projects in Development

• com – a unique CBD website that will host a variety of Budtender rated CBD products. Visitors will have the option to choose from a variety of products suited to their specific needs. Consumers will be provided with independent reviews of their preferred products, along with suggested ways for use. The Budtender Select shopping cart feature will provide consumers with a convenient and straightforward purchase method.
• com – set to be a digital newsletter to cross between RMH brands, specifically with the Canna Paid and Budtender Awards platforms. HighLifestyle.com will be a destination where people can populate, design, and share lifestyle-related content. The nature of this platform is to provide a robust social connection along with the ability to aggregate this collected data for market intelligence.

Leadership

Keith Allen, Chief Executive Officer, Managing Director
Keith Allen has vast executive and operational experience. Allen was formerly the marketing communications expert for ivyKoin, a blockchain-based cryptocurrency for business transactions required extensive verification in the international monetary system, where he helped design the infrastructure and go to market strategy. His other executive experience includes the title of chairman and CEO of a global dental company with products in thousands of retail stores throughout the world. His combined experience with both financial and CPG markets uniquely qualifies Allen to execute and scale the operational goals of Canna Paid and RMH.

Ryan Bridges, Banking & Business Development Officer, Director
Ryan Bridges has extensive investment banking experience with Direct Capital Securities and the California Capital Access Fund, including over 15 years of electronic payment and business development services. Bridges’ extensive operational and developmental expertise was instrumental in generating landmark successes for Radius Payments, Inc. and Payment Insights, LLC. Canna Paid and RMH are the direct benefactors of Bridges’ input and strategic guidance.

* In the first round of financing, Round Meadow Holdings has raised 3mm to date and is currently in phase two raising an additional 2mm for expansions purposes.

For more information, visit the company’s website at www.RMHCorp.com

NOTE TO INVESTORS: The latest news and updates relating to RMH are available in the company’s newsroom at http://ibn.fm/RMH

• Data shows that 83% of global Internet users regularly share online content on a monthly basis
• Internet users are turning toward online communities as places where they can express themselves
• Jerrick’s Vocal platform, along with its Vocal+ premium-subscription membership program, ranks among top online creator platforms

Online communities are on the rise, according to a recent report released by GlobalWebIndex and Reddit. The report, titled “The era of We and the rise of online communities,” notes that Online community sites have become the go-to platforms for the growing amount of user-generated content posted online (http://ibn.fm/vCXjn). Jerrick Media Holdings Inc. (OTC: JMDA) and its proprietary publishing platform Vocal are leading the way in this growing trend.

“We’re now sharing huge amounts of content online – from photos and videos to product reviews,” the study reported. “Our data shows that in 2019, 83% of global Internet users regularly share this kind of information online on a monthly basis, and this is a truly cross-demographic activity, ranging from 70% of Boomers to almost 90% of Gen Z and Millennials.”

Though much of this content was historically shared on social media sites such as Facebook, Instagram and Twitter, along with video sites such as YouTube, the report noted that what the online community is sharing – and where it is shared – is changing.

“For authentic connections, Internet users are increasingly turning toward online communities as places where they can express themselves,” the report states. “In the U.S., 64% of online community site visitors say they’re visiting those sites more often now than they did a couple of years ago, and 46% say the sites have become more important to them over time. Online communities provide a place for genuine human connection and belonging in the digital world. On them, we can meet people who share our interests, learn from others, and have meaningful conversations.”

That’s precisely the type of community that creators and community members find on Vocal. Jerrick’s online platform is built on the idea of community of individuals, businesses and audiences brought together by a common interest or goal. Vocal’s genre-specific communities (http://ibn.fm/eDeWZ) span topics ranging from health and wellness to beauty, food, women’s issues, gaming, mental health, and more. Individuals use these virtual communities of transaction to buy, sell or learn more about products and services; to discuss shared interests; to develop social relations; and to explore new identities.

Savvy brands that tap into these powerful virtual communities, such as through Vocal’s branded content studio, Vocal for Brands (http://ibn.fm/WSf5T), can experience significant benefits, including increased sales, positive word‐of‐mouth, more effective market segmentation, increased website traffic, stronger brand, higher advertising and transaction fee revenue, and better product support and service delivery.

“These spaces offer marketers an opportunity to connect with consumers in a more meaningful and authentic way,” the report said. “Online communities have become an important touchpoint across the consumer journey, especially among younger generations – and our research shows that there’s a big appetite among the majority of online community participators for brands to join the conversation and have a voice. This marketing channel offers brands a way of staying ahead of emerging expectations, giving consumers a sense of involvement, and ultimately deepening their connection with today’s consumers.”

Jerrick’s Vocal platform, which includes a premium membership program called Vocal+ (http://ibn.fm/RNi6K), ranks among the top online creator platforms in the digital world, with approximately 565,000 registered creators to date. “Vocal is a technology platform that is of a caliber associated with only a few hundred other digital platforms,” Jerrick CEO Jeremy Frommer stated in a news release (http://ibn.fm/gU8H7), who noted that the company spent nearly six years studying and researching in order to create the platform.

Jerrick Media Holdings is focused on the development of digital communities, targeted marketing of branded digital content and e-commerce opportunities. To accomplish these objectives, Jerrick envisions, designs and builds modern technology companies that redefine how people interact with technology. As the parent company of Vocal, Jerrick has built and shipped products that have influenced millions of people worldwide.

Those interested in weekly news from Jerrick can sign up at http://ibn.fm/CYErP

For more information, visit the company’s website at https://Jerrick.media

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://ibn.fm/JMDA

• BINGE partners with creators to deliver innovative, all-in-one content distribution
• Content creators who choose BINGE receive revenue from three different sources
• Signing up with BINGE is simple, three-step process

BINGE Networks, a pioneer in the content distribution and monetization solution, works closely with creators to deliver an all-in-one content distribution system supplemented. With some 200 channels covering dozens of genres, BINGE is able to deliver powerfully on its simple mission: to get creators paid on their video content.

In addition to having a simple mission, BINGE has made using its service simple; signing up involves a three-step process (http://ibn.fm/cUiLX).

• Step one: Content creators work with BINGE to build their channels; they can choose pay-per-view or subscription.
• Step two: BINGE builds the channel app, drives traffic to the channel, and even runs ads for the channel, and the content creator gets paid — guaranteed.
• Step three: The channel distribution is distributed on more than 90 OTT platforms, achieving immediate global reach.

“We wanted to create the Netflix experience for the everyday creator, so they can earn revenues on the content they worked so hard to create,” BINGE founder and CEO Bonnie Bruderer stated in a news release. “Many filmmakers and creators don’t get distribution contracts from the larger networks, so we wanted to solve for that problem.”

Content creators who choose BINGE receive revenue from three different sources: 50% commission on subscription and pay-per-view channels (BINGE believes every great relationship should be 50/50), monetization on premium apps, and distribution on Binge’s 90-plus OTT networks.

“As a professional TV chef, I am always looking for ways to optimize my content,” said Chef Ace Champion, content creator for the “Cook Like a Champion” channel. “BINGE Networks has been a dream come true. The process was so simple, and the uploading was even easier. I love knowing that within minutes my content is available on platforms all around the world. I would recommend BINGE Networks as one of the top video optimizers around.”

Launched in 2018, BINGE Networks is a decentralized VOD platform that offers premium content using blockchain’s transparent and secure distributed ledger technology. The network provides a business model of equitable compensation based on complete economic transparency. The platform is designed to deliver low-cost, high-speed, high-definition video globally, as well as transparent real-time payments and view metrics – a key differentiator from other VOD platforms.

BINGE creators and viewer can choose content from all types of genres – from animals and business to women and yoga and everything in between. Its 200 channels are available over an impressive distribution system that includes Apple TV, Amazon FireTV, Roku, Google Play and almost a hundred others.

BINGE Networks’ message is simple as well: “Your content deserves to be seen. We make that happen. Distribution, Monetization, Exposure. We can help.”

BINGE is the solution for smart TV distribution and monetization. With the BINGE Networks app on more than 200 smart TV platforms and premium syndication on platforms such as TikiLive, Zingo TV and Video Elephant, BINGE is the one-stop-shop for all things video monetization and distribution.

For more information, visit the company’s website at www.BINGENetworks.tv